Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Jun 28, 2025
Revenue increased compared to the prior quarter and also rose relative to the same quarter last year. The sequential improvement reversed the decline seen in the immediately preceding quarter.
Key takeaway
Quarter ended Jun 28, 2025 · FY2025 Q2
Revenue increased compared to the prior quarter and also rose relative to the same quarter last year. The sequential improvement reversed the decline seen in the immediately preceding quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.9B
Revenue reported for this quarter.
Quarter-over-quarter
+4.7%
Change from the immediately preceding quarter.
Year-over-year
+3.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$43.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 28, 2024 | $10.6B | +0.2% |
| Dec 31, 2024 | $11.4B | +4.7% |
| Mar 29, 2025 | $10.4B | +0.2% |
| Jun 28, 2025 | $10.9B | +3.0% |
Revenue performance
The reported revenue for the quarter was higher than both the preceding quarter and the year-ago period. This marks a return to sequential growth after a decline in the prior quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased. Versus the same quarter one year earlier, revenue also showed an increase.
What to watch
The sequential revenue growth follows a decline in the prior quarter, warranting attention to the sustainability of this trend.